US 11,717,682 B2
Apparatus and method for relieving pain using transcutaneous electrical nerve stimulation
Shai N. Gozani, Newton, MA (US); Xuan Kong, Acton, MA (US); Andres Aguirre, Belmont, MA (US); Glenn Herb, Weston, MA (US); Marc Cryan, Maynard, MA (US); and Michael Williams, Melrose, MA (US)
Assigned to NeuroMetrix, Inc, Woburn, MA (US)
Filed by NeuroMetrix, Inc., Woburn, MA (US)
Filed on Sep. 22, 2020, as Appl. No. 17/28,055.
Application 17/028,055 is a continuation of application No. 15/602,611, filed on May 23, 2017, granted, now 10,780,269.
Application 15/602,611 is a continuation of application No. 14/610,757, filed on Jan. 30, 2015, granted, now 9,656,070, issued on May 23, 2017.
Application 14/610,757 is a continuation of application No. 13/678,221, filed on Nov. 15, 2012, granted, now 8,948,876, issued on Feb. 3, 2015.
Claims priority of provisional application 61/657,382, filed on Jun. 8, 2012.
Claims priority of provisional application 61/560,029, filed on Nov. 15, 2011.
Prior Publication US 2021/0069507 A1, Mar. 11, 2021
Int. Cl. A61N 1/36 (2006.01); A61N 1/04 (2006.01); A61N 1/32 (2006.01); A61N 1/372 (2006.01)
CPC A61N 1/36014 (2013.01) [A61N 1/0456 (2013.01); A61N 1/0476 (2013.01); A61N 1/0492 (2013.01); A61N 1/321 (2013.01); A61N 1/36021 (2013.01); A61N 1/36034 (2017.08); A61N 1/37247 (2013.01); A61N 1/36031 (2017.08)] 19 Claims
OG exemplary drawing
 
1. A method for setting the therapeutic stimulation intensity for transcutaneous electrical nerve stimulation in humans, the method comprising the steps of:
initiating a transcutaneous electrical nerve stimulation session for a user at a first therapeutic stimulation intensity;
automatically adjusting the first therapeutic stimulation intensity at a pre-determined adjustment rate, wherein the pre-determined adjustment rate is fixed during the transcutaneous electrical nerve stimulation session;
responding to commands from the user for manual changes in the therapeutic stimulation intensity;
continuing the transcutaneous electrical nerve stimulation session for a period of time; and
updating at least one of the first therapeutic stimulation intensity and the pre-determined adjustment rate for future transcutaneous electrical stimulation sessions based on accumulative changes initiated by the user.